Top Stories This Week

General Medicine Breaking News
By Erika Powers VIRTUAL -- April 21, 2021 -- Use of hormone therapy among menopausal women appears to be associated with an increased risk of incident hypertension, especially when using oral oestrogen and pregnane and norpregnane derivative in case of combined treatment, according to a study...
By Erika Powers VIRTUAL -- April 21, 2021 -- Lowering blood pressure reduces the risk of new-onset diabetes, but the protective effect is not uniform among different antihypertensive classes, according to a study presented at the Virtual 2021 Joint Meeting of the European Society of Hypertension (...
By Erika Powers VIRTUAL -- April 21, 2021 -- Pharmaceutical blood pressure (BP)-lowering does not appear to have an important effect on cancer risk, according to a large meta-analysis presented at the Virtual 2021 Joint Meeting of the European Society of Hypertension (ESH) and the International...
By Erika Powers VIRTUAL -- April 19, 2021 -- Systolic inter-arm blood pressure differences of ≥5 mm Hg and ≥10 mm Hg appear to be associated with onset of mild cognitive impairment (MCI), according to a study presented at the Virtual 2021 Joint Meeting of the European Society of Hypertension (ESH...
By Jenny Powers VIRTUAL -- April 13, 2021 -- The use of esketamine nasal spray for patients with treatment-resistant depression is supported by a safety profile demonstrating that most adverse events are mild and transient, according to a study presented at the Virtual 29th European Congress of...
By Jenny Powers VIRTUAL -- April 13, 2021 – Real-world data confirm that vortioxetine is effective and tolerable in patients with major depressive disorder (MDD), researchers reported at the Virtual 29th European Congress of Psychiatry (European Psychiatric Association [EPA]). “Patients’ overall...
Coexisting visual and hearing impairments facilitate dementia prevalence, dementia incidence, and cognitive decline, according to a study published in the journal Neurology. “Depending on the degree of hearing or vision loss, losing function in your senses can be distressing and have an impact on...
After a detailed review of available literature, the American Gastroenterological Association (AGA) has released new clinical guidelines recommending the use of intragastric balloons (IGB) for patients with obesity who have not been able to lose weight with traditional weight-loss strategies. This...
The US Food and Drug Administration (FDA) approved alirocumab (Praluent) as add-on therapy for adult patients with homozygous familial hypercholesterolaemia (HoFH). Alirocumab works by stopping the proprotein convertase subtilisin kexin type 9 (PCSK9) protein, which controls the number of low-...
By Louise Gagnon OTTAWA, Ontario -- March 26, 2021 -- Interventions to improve sleep in military service members with post-traumatic stress disorder (PTSD) did not improve sleep but did result in decreased post-traumatic stress arousal, depressive symptoms, and inflammatory markers, according to a...

Pages